Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | CFTR | P13569 | 1/20 | 0.31 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1097512 | 0.95 | ALDH1A1 (0.41) | ALDH1A1MAPTSMN1; SMN2SLC22A2SLC22A1 | |
| SCHEMBL23433023 | 0.69 | PDE4B (0.33) | ALDH1A1MAPT | |
| SCHEMBL22698818 | 0.68 | TAAR1 (0.35) | CFTRGOPC | |
| SCHEMBL24633311 | 0.68 | MGLL (0.35) | — | |
| Biphenyl SCHEMBL27335698 | 0.67 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL27827084 | 0.67 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL19834896 | 0.67 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL10789398 | 0.65 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL27964305 | 0.65 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2SLC22A2SLC22A1SLC22A3 | |
| Biphenyl SCHEMBL27354128 | 0.65 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2SLC22A2SLC22A1SLC22A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1046389-B1 | Cosnetic composition in particular a make-up composition comprising a pyrrolopyrrole pigment | OREAL (FR) | 2003-08-13 | — | — | EP | claimed |
| US-6372202-B1 | Cosmetic composition, in particular a make-up composition, comprising a pigment derived from pyrrolopyrrole | L'OREAL (FR) | 2002-04-16 | — | — | US | claimed |
| US-5785750-A | A QUINACRIDONE DYES PROMOTING PIGMENT DISPERSION FOR AUTOMOBILE FINISH | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-07-28 | — | — | US | claimed |
| US-4298741-A | DETHIAPENICILLIN ANTIBIOTICS | MERCK & CO., INC. (US) | 1981-11-03 | — | — | US | claimed |
| WO-2024071364-A1 | POLYMER COMPOSITION AND SINGLE-LAYER RETARDATION MATERIAL | 日産化学株式会社 | 2024-04-04 | — | — | WO | disclosed |
| CN-116261343-A | Organic light emitting display device | 乐金显示有限公司 | 2023-06-13 | — | — | CN | disclosed |
| WO-2023008488-A1 | POLYMER COMPOSITION AND SINGLE-LAYER RETARDATION MATERIAL | 日産化学株式会社 | 2023-02-02 | — | — | WO | disclosed |
| US-20230026457-A1 | ELECTRODE MATERIAL | WASEDA UNIVERSITY (JP) | 2023-01-26 | — | — | US | disclosed |
| US-11130855-B2 | Composition for forming release layer, and release layer | NISSAN CHEMICAL CORPORATION (JP) | 2021-09-28 | — | — | US | disclosed |
| US-20210276988-A1 | 4,6-DI- AND 2,4,6-TRISUBSTITUTED QUINAZOLINE DERIVATIVES USEFUL FOR TREATING VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2021-09-09 | — | — | US | disclosed |
| WO-2021149705-A1 | COMPOSITION FOR FORMING RELEASE LAYER FOR ALKALI GLASS, AND RELEASE LAYER | 日産化学株式会社 | 2021-07-29 | — | — | WO | disclosed |
| WO-2021132383-A1 | COMPOSITION FOR FORMING RELEASE LAYER, AND RELEASE LAYER | 日産化学株式会社 | 2021-07-01 | — | — | WO | disclosed |
| EP-0068813-B1 | FUNGICIDAL 1,2,4-TRIAZOLE AND IMIDAZOLE DERIVATIVES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-09-25 | — | — | EP | disclosed |
| US-4428960-A | AMINO ACID DERIVATIVE ANTIBIOTICS | MERCK & CO., INC. (US) | 1984-01-31 | — | — | US | disclosed |
| US-4388310-A | ANTIBIOTIC | MERCK & CO., INC. (US) | 1983-06-14 | — | — | US | disclosed |
| US-4374849-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1983-02-22 | — | — | US | disclosed |
| US-4298741-A | DETHIAPENICILLIN ANTIBIOTICS | MERCK & CO., INC. (US) | 1981-11-03 | — | — | US | disclosed |
| US-4217453-A | BACTERICIDES, ANTIBIOTICS | MERCK & CO., INC. (US) | 1980-08-12 | — | — | US | disclosed |
| US-4157262-A | Intensification of photographic silver images by physical development and improvement in physical developer solution for use therein | FUJI PHOTO FILM CO., LTD. (JP) | 1979-06-05 | — | — | US | disclosed |
| US-3944627-A | TO ALKYLBENZENES, GROUP 8 METAL SUPPORTED CATALYST | SHELL OIL COMPANY (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210276988-A1 | 4,6-DI- AND 2,4,6-TRISUBSTITUTED QUINAZOLINE DERIVATIVES USEFUL FOR TREATING VIRAL INFECTIONS | NR3C1, NR3C2, NR4A1 | ALDH1A1 2743/4885MAPT 4544/4885SMN1; SMN2 3900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.